Log in to save to my catalogue

Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs

Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8393277

Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs

About this item

Full title

Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs

Publisher

London: Nature Publishing Group UK

Journal title

Bone marrow transplantation (Basingstoke), 2019-07, Vol.54 (7), p.1089-1093

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Primary plasma cell leukemia (pPCL) is a rare and aggressive variant of multiple myeloma (MM) with poor long-term survival after cytotoxic chemotherapy. Many novel drugs have revolutionized the treatment algorithms for MM. The impact of targeted therapy, both pre- and post-autologous stem cell transplant (auto-HCT) remains an area of ongoing intere...

Alternative Titles

Full title

Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8393277

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8393277

Other Identifiers

ISSN

0268-3369

E-ISSN

1476-5365

DOI

10.1038/s41409-018-0392-1

How to access this item